RU2005126678A - METHOD FOR PREVENTION OF HYPERTENSION II STAGE WITH CRISIS - Google Patents

METHOD FOR PREVENTION OF HYPERTENSION II STAGE WITH CRISIS Download PDF

Info

Publication number
RU2005126678A
RU2005126678A RU2005126678/14A RU2005126678A RU2005126678A RU 2005126678 A RU2005126678 A RU 2005126678A RU 2005126678/14 A RU2005126678/14 A RU 2005126678/14A RU 2005126678 A RU2005126678 A RU 2005126678A RU 2005126678 A RU2005126678 A RU 2005126678A
Authority
RU
Russia
Prior art keywords
blood pressure
monitor
patient
stage
program unit
Prior art date
Application number
RU2005126678/14A
Other languages
Russian (ru)
Inventor
Николай Павлович Миронов (RU)
Николай Павлович Миронов
Александр Иванович Романов (RU)
Александр Иванович Романов
Григорий Петрович Дорошенко (RU)
Григорий Петрович Дорошенко
Сергей Николаевич Пантелеев (RU)
Сергей Николаевич Пантелеев
Владимир Валерьевич Шамин (RU)
Владимир Валерьевич Шамин
Дмитрий Юрьевич Каллистов (RU)
Дмитрий Юрьевич Каллистов
Наталь Николаевна Савицка (RU)
Наталья Николаевна Савицкая
Елена В чеславовна Матвеева (RU)
Елена Вячеславовна Матвеева
Светлана Евгеньевна Хатькова (RU)
Светлана Евгеньевна Хатькова
Original Assignee
Общество с ограниченной ответственностью "Эпидавр" (RU)
Общество с ограниченной ответственностью "Эпидавр"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Эпидавр" (RU), Общество с ограниченной ответственностью "Эпидавр" filed Critical Общество с ограниченной ответственностью "Эпидавр" (RU)
Priority to RU2005126678/14A priority Critical patent/RU2005126678A/en
Publication of RU2005126678A publication Critical patent/RU2005126678A/en

Links

Landscapes

  • External Artificial Organs (AREA)

Claims (1)

Способ профилактики, гипертонической болезни II стадии с кризовым течением, выполняемый медиуаментозными средствами под контролем локального измерителя АД, отличающийся тем, что пациенту в стационаре на этапе стабилизации АД выдают телемонитор АД и в течение 5 дней утром, в обед, вечером и в периоды дискомфорта регистрируют АД, вычисляют индивидуальное значение АД, прогнозируют вероятные периоды ежесуточного обострения и заносят данные показатели в программный блок и таймер в качестве уставок для сравнения в указанном мониторе, выписывают пациента из стационара с передачей монитора АД в длительное пользование и в условиях повседневной жизни рекомендуют проводить измерения АД три раза в день, при ухудшении состояния, по команде от лечащего врача, от телемедицинского центра, по сигналам системы сравнения АД в программном блоке или по вызову таймера, в случае превышения АД на 25% от указанного в программном блоке индивидуального значения, проводят повторное измерение АД через 15 мин и при сохранении повышенного АД рекомендуют пациенту принять короткодействующий препарат из группы блокаторов кальциевых каналов, а через 2 ч выполнить контрольное измерение АД и в случае отклонения от нормы запрашивают врачебную рекомендацию по каналам связи указанного монитора АД.A method for the prevention of stage II hypertension with a critical course, performed by mediation drugs under the control of a local blood pressure meter, characterized in that a patient is given a blood pressure monitor at the stage of blood pressure stabilization and is recorded for 5 days in the morning, afternoon, evening and during periods of discomfort HELL, calculate the individual HELL value, predict the probable periods of daily exacerbation, and enter these indicators into the program unit and timer as settings for comparison in the indicated monitor, writing out they recommend a patient from the hospital with the transfer of the blood pressure monitor for long-term use and in everyday life, it is recommended to take blood pressure measurements three times a day, if the condition worsens, on command from the attending physician, from the telemedicine center, according to the signals of the blood pressure comparison system in the program unit or by calling timer, in case of excess of blood pressure by 25% of the individual value indicated in the program unit, a second blood pressure measurement is carried out after 15 minutes and while maintaining high blood pressure, the patient is recommended to take a short-acting drug and the group of calcium channel blockers, and after 2 hours to perform a control measurement of blood pressure and in case of deviation from the normal request medical recommendation for communication channels of said monitor blood pressure.
RU2005126678/14A 2005-08-24 2005-08-24 METHOD FOR PREVENTION OF HYPERTENSION II STAGE WITH CRISIS RU2005126678A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2005126678/14A RU2005126678A (en) 2005-08-24 2005-08-24 METHOD FOR PREVENTION OF HYPERTENSION II STAGE WITH CRISIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2005126678/14A RU2005126678A (en) 2005-08-24 2005-08-24 METHOD FOR PREVENTION OF HYPERTENSION II STAGE WITH CRISIS

Publications (1)

Publication Number Publication Date
RU2005126678A true RU2005126678A (en) 2007-02-27

Family

ID=37990458

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005126678/14A RU2005126678A (en) 2005-08-24 2005-08-24 METHOD FOR PREVENTION OF HYPERTENSION II STAGE WITH CRISIS

Country Status (1)

Country Link
RU (1) RU2005126678A (en)

Similar Documents

Publication Publication Date Title
Maiolo et al. Home telemonitoring for patients with severe respiratory illness: the Italian experience
Chenniappan Blood pressure variability: assessment, prognostic significance and management.
US20090043214A1 (en) Sphygmomanometer capable of knowing variation in blood pressure value
Mayor Hypertension diagnosis should be based on ambulatory blood pressure monitoring, NICE recommends
Gosse et al. Effect of telmisartan vs. ramipril on ‘dipping’status and blood pressure variability: pooled analysis of the PRISMA studies
Larochelle Circadian variation in blood pressure: dipper or nondipper
Calvo et al. The ‘ABPM effect’gradually decreases but does not disappear in successive sessions of ambulatory monitoring
US20140364717A1 (en) Method and device for continuous measurement of intraocular pressures
CN101442930B (en) Device for drug administration and/or monitoring status of patient
Cox et al. A comparison of the twenty-four-hour blood pressure profile in normotensive and hypertensive subjects
RU2005126678A (en) METHOD FOR PREVENTION OF HYPERTENSION II STAGE WITH CRISIS
Huang et al. Comparative study on daytime and nighttime blood pressure monitoring between routine ambulatory blood pressure monitoring and the combined use of the Omron HEM-6410T watch and HEM-9601T wrist devices
Huang et al. Antihypertensive treatment in masked hypertension for target organ protection (ANTI-MASK): a randomized, double-blind, placebo-controlled trial
Andersson et al. PERSON-CENTREDNESS IN HYPERTENSION MANAGEMENT USING INFORMATION TECHNOLOGY (PERHIT): A RANDOMISED CONTROLLED TRIAL IN PRIMARY HEALTH CARE
Girerd et al. EVALUATION OF A DIGITAL THERAPY FOR UNCONTROLLED HYPERTENSIVE PATIENTS FOLLOWED BY GENERAL PRACTITIONERS IN FRANCE
CN114300088B (en) Body temperature monitoring device and system for guiding perimenopausal hormone replacement therapy
Ntineri et al. 3c. 05: Diagnostic agreement of the European Society of Hypertension Home Blood Monitoring Schedule with ambulatory blood pressure monitoring in untreated and treated subjects
Anjum et al. 24-Hour chronomics of ambulatory blood pressure monitoring in rotating night shift workers and controls
Girerd et al. HOW MANY DAYS TO CONFIRM HYPERTENSION USING HOME BOOD PRESSURE MONITORING
Girerd et al. ADVANTAGES AND LIMITATIONS OF USING THE AKTIIA CUFFLESS BRACELET FOR A HYPERTENSION SPECIALIST
Gouveia et al. ORTHOSTATIC HYPOTENSION AT DISCHARGE-ASSOCIATED CHARACTERISTICS AND OUTCOMES
Chen et al. P-609: Effect of antihypertensive treatment on utilization of acute care services
Fariello et al. P-66: Pattern and distributon of pulse pressure from young to elderly hypertensives
Vornovitsky et al. Ambulatory blood pressure monitoring: Is 24 hours necessary?
Polonia et al. P-68: Attempt to define the upper normal limits of ambulatory blood pressure for the critical morning and evening periods